Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data

被引:124
作者
Houtman, Corine J. [1 ]
Kroesbergen, Jan [1 ]
Lekkerkerker-Teunissen, Karin [2 ]
van der Hoek, Jan Peter [3 ,4 ]
机构
[1] Water Lab, NL-2003 RS Haarlem, Netherlands
[2] Dunea Dune & Water, Zoetermeer, Netherlands
[3] Delft Univ Technol, Delft, Netherlands
[4] Waternet, Amsterdam, Netherlands
关键词
Mixture toxicity; Threshold of toxicological concern; Exposure assessment; Pharmaceuticals; Drinking water; PERSONAL CARE PRODUCTS; ENDOCRINE DISRUPTING COMPOUNDS; SITE WASTE-WATER; SURFACE WATERS; EMERGING CONTAMINANTS; ESTROGENIC ACTIVITY; ENVIRONMENT; REMOVAL; DRUGS; PERFORMANCE;
D O I
10.1016/j.scitotenv.2014.07.022
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The presence of pharmaceuticals in drinking water is a topic of concern. Previous risk assessments indicate that their low concentrations are very unlikely to pose risks to human health, however often conclusions had to be based on small datasets and mixture effects were not included. The objectives of this study were to a) investigate if pharmaceuticals in surface and polder water penetrate in drinking water, b) assess the lifelong exposure of consumers to pharmaceuticals via drinking water and c) assess the possible individual and mixture health risks associated with this exposure. To fulfill these aims, a 2-year set of 4-weekly monitoring data of pharmaceuticals was used from three drinking water production plants. The 42 pharmaceuticals that were monitored were selected according to their consumption volume, earlier detection, toxicity and representation of the most relevant therapeutic classes. Lifelong exposures were calculated from concentrations and compared with therapeutic doses. Health risks were assessed by benchmarking concentrations with provisional guideline values. Combined risks of mixtures of pharmaceuticals were estimated using the concept of Concentration Addition. The lifelong exposure to pharmaceuticals via drinking water was calculated to be extremely low, i.e. a few mg, in total corresponding to <10% of the dose a patient is administered on one day. The risk of adverse health effects appeared to be negligibly low. Application of Concentration Addition confirmed this for the mixture of pharmaceuticals simultaneously present The investigated treatment plants appeared to reduce the (already negligible) risk up to 80%. The large available monitoring dataset enabled the performance of a realistic risk assessment. It showed that working with maximum instead of average concentrations may overestimate the risk considerably. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:54 / 62
页数:9
相关论文
共 47 条
  • [1] [Anonymous], 2004, DRINKWATER PRINCIPES
  • [2] Predictive Environmental Risk Assessment of Chemical Mixtures: A Conceptual Framework
    Backhaus, Thomas
    Faust, Michael
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2012, 46 (05) : 2564 - 2573
  • [3] Bannink A., 2012, JAARRAPORT 2011 MAAS, P1
  • [4] Bauerlein P., 2013, BTO2013049 KWR WAT R, P1
  • [5] Evaluation of a photocatalytic reactor membrane pilot system for the removal of pharmaceuticals and endocrine disrupting compounds from water
    Benotti, Mark J.
    Stanford, Benjamin D.
    Wert, Eric C.
    Snyder, Shane A.
    [J]. WATER RESEARCH, 2009, 43 (06) : 1513 - 1522
  • [6] Pharmaceuticals and Endocrine Disrupting Compounds in US Drinking Water
    Benotti, Mark J.
    Trenholm, Rebecca A.
    Vanderford, Brett J.
    Holady, Janie C.
    Stanford, Benjamin D.
    Snyder, Shane A.
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2009, 43 (03) : 597 - 603
  • [7] Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment
    Boobis, Alan
    Budinsky, Robert
    Collie, Shanna
    Crofton, Kevin
    Embry, Michelle
    Felter, Susan
    Hertzberg, Richard
    Kopp, David
    Mihlan, Gary
    Mumtaz, Moiz
    Price, Paul
    Solomon, Keith
    Teuschler, Linda
    Yang, Raymond
    Zaleski, Rosemary
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 2011, 41 (05) : 369 - 383
  • [8] Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?
    Boxall, Alistair B. A.
    Rudd, Murray A.
    Brooks, Bryan W.
    Caldwell, Daniel J.
    Choi, Kyungho
    Hickmann, Silke
    Innes, Elizabeth
    Ostapyk, Kim
    Staveley, Jane P.
    Verslycke, Tim
    Ankley, Gerald T.
    Beazley, Karen F.
    Belanger, Scott E.
    Berninger, Jason P.
    Carriquiriborde, Pedro
    Coors, Anja
    DeLeo, Paul C.
    Dyer, Scott D.
    Ericson, Jon F.
    Gagne, Francois
    Giesy, John P.
    Gouin, Todd
    Hallstrom, Lars
    Karlsson, Maja V.
    Larsson, D. G. Joakim
    Lazorchak, James M.
    Mastrocco, Frank
    McLaughlin, Alison
    McMaster, Mark E.
    Meyerhoff, Roger D.
    Moore, Roberta
    Parrott, Joanne L.
    Snape, Jason R.
    Murray-Smith, Richard
    Servos, Mark R.
    Sibley, Paul K.
    Straub, Juerg Oliver
    Szabo, Nora D.
    Topp, Edward
    Tetreault, Gerald R.
    Trudeau, Vance L.
    Van Der Kraak, Glen
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2012, 120 (09) : 1221 - 1229
  • [9] Toxicological Relevance of Pharmaceuticals in Drinking Water
    Bruce, Gretchen M.
    Pleus, Richard C.
    Snyder, Shane A.
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2010, 44 (14) : 5619 - 5626
  • [10] Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid
    Cleuvers, M
    [J]. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2004, 59 (03) : 309 - 315